BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9448590)

  • 1. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides.
    Gayraud M; Guillevin L; Cohen P; Lhote F; Cacoub P; Deblois P; Godeau B; Ruel M; Vidal E; Piontud M; Ducroix JP; Lassoued S; Christoforov B; Babinet P
    Br J Rheumatol; 1997 Dec; 36(12):1290-7. PubMed ID: 9448590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
    Guillevin L; Lhote F; Gayraud M; Cohen P; Jarrousse B; Lortholary O; Thibult N; Casassus P
    Medicine (Baltimore); 1996 Jan; 75(1):17-28. PubMed ID: 8569467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.
    Guillevin L; Lhote F; Cohen P; Jarrousse B; Lortholary O; Généreau T; Léon A; Bussel A
    Arthritis Rheum; 1995 Nov; 38(11):1638-45. PubMed ID: 7488285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.
    Guillevin L; Jarrousse B; Lok C; Lhote F; Jais JP; Le Thi Huong Du D; Bussel A
    J Rheumatol; 1991 Apr; 18(4):567-74. PubMed ID: 1676753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A meta-analysis of 3 prospective controlled trials including 182 patients over 12 years.
    Guillevin L; Lhote F; Jarrousse B; Fain O
    Ann Med Interne (Paris); 1992; 143(6):405-16. PubMed ID: 1363508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.
    Guillevin L; Fain O; Lhote F; Jarrousse B; Le Thi Huong D; Bussel A; Leon A
    Arthritis Rheum; 1992 Feb; 35(2):208-15. PubMed ID: 1346499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients.
    Généreau T; Lortholary O; Leclerq P; Grenet D; Tubéry M; Sicard D; Caubarrère I; Guillevin L
    Br J Rheumatol; 1994 Oct; 33(10):959-62. PubMed ID: 7921758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: indications of plasma exchanges.
    Guillevin L; Lhote F
    Transfus Sci; 1994 Dec; 15(4):371-88. PubMed ID: 10155556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of polyarteritis nodosa and Churg-Strauss angiitis: indications of plasma exchange. Results of three prospective trials in 162 patients. The Cooperative Study Group for the Study of Polyarteritis Nodosa.
    Guillevin L
    Prog Clin Biol Res; 1990; 337():309-17. PubMed ID: 1972283
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
    Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
    Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclophosphamide in treatment of polyarteritis nodosa?
    Conn DL
    J Rheumatol; 1991 Apr; 18(4):489-90. PubMed ID: 1676751
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genital papules revealing a Churg-Strauss syndrome].
    Rivollier C; Martin L; Machet L; Machet MC; Lorette G
    Ann Dermatol Venereol; 2002; 129(8-9):1049-52. PubMed ID: 12442106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
    Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.
    Guillevin L; Cohen P; Mahr A; Arène JP; Mouthon L; Puéchal X; Pertuiset E; Gilson B; Hamidou M; Lanoux P; Bruet A; Ruivard M; Vanhille P; Cordier JF
    Arthritis Rheum; 2003 Feb; 49(1):93-100. PubMed ID: 12579599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When should immunosuppressants be prescribed to treat systemic vasculitides?
    Guillevin L; Pagnoux C
    Intern Med; 2003 Apr; 42(4):313-7. PubMed ID: 12729318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Churg-Strauss syndrome and polyarteritis nodosa.
    Lightfoot RW
    Curr Opin Rheumatol; 1991 Feb; 3(1):3-7. PubMed ID: 1675114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.
    Martin-Suarez I; D'Cruz D; Mansoor M; Fernandes AP; Khamashta MA; Hughes GR
    Ann Rheum Dis; 1997 Aug; 56(8):481-7. PubMed ID: 9306871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.
    Semple D; Keogh J; Forni L; Venn R
    Crit Care; 2005 Apr; 9(2):193-7. PubMed ID: 15774077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic necrotizing vasculitides in Turkey: a comparative analysis of 40 consecutive patients.
    Kamali S; Inanc M; Gul A; Ocal L; Polat NG; Kilicaslan I; Aral O; Konice M
    Rheumatol Int; 2005 Nov; 26(1):16-20. PubMed ID: 15372200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.